Keros Therapeutics Overview
Keros Therapeutics Target Price
Analysts' 12-month price predictions for KROS.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.24
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-11-05 | JefferiesKelly Shi | $107 |  944.9% upside |  |
| 2024-11-05 | Truist FinancialSrikripa Devarakonda | $100 | 876.6% upside | |
| 2024-09-23 | GuggenheimVamil Divan | $96 | 837.5% upside | |
| 2024-06-18 | Piper SandlerJoseph Catanzaro | $105 | 925.4% upside | |
| 2022-12-13 | BTIG | $105 | 925.4% upside | |
| 2022-07-27 | BTIGJulian Harrison | $80 | 681.3% upside | |
| 2022-05-18 | Piper SandlerJoseph Catanzaro | $120 | 1071.9% upside | |